Topics

New Jersey OTC Firm Lacked GMP Basics, FDA Warning Letter Says

14:14 EST 15 Jan 2020 | SCRIP

US FDA warns that Health Pharma USA was shipping product before its quality unit could review and test it.

      

Related Stories

 

Original Article: New Jersey OTC Firm Lacked GMP Basics, FDA Warning Letter Says

NEXT ARTICLE

More From BioPortfolio on "New Jersey OTC Firm Lacked GMP Basics, FDA Warning Letter Says"

Quick Search

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...